Janney Montgomery Scott LLC Esperion Therapeutics, Inc. Transaction History
Janney Montgomery Scott LLC
- $38.3 Billion
- Q2 2025
A detailed history of Janney Montgomery Scott LLC transactions in Esperion Therapeutics, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 12,050 shares of ESPR stock, worth $21,569. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,050
Previous 12,550
3.98%
Holding current value
$21,569
Previous $18,000
33.33%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ESPR
# of Institutions
183Shares Held
106MCall Options Held
139KPut Options Held
604K-
Black Rock Inc. New York, NY14MShares$25 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.7MShares$21 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT10.3MShares$18.5 Million0.05% of portfolio
-
Two Seas Capital LP Rye, NY9.95MShares$17.8 Million0.18% of portfolio
-
Pender Fund Capital Management Ltd. Vancouver, A16.68MShares$12 Million4.26% of portfolio
About Esperion Therapeutics, Inc.
- Ticker ESPR
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 66,551,600
- Market Cap $119M
- Description
- Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...